Past Events
Invited Speakers
Aaron Hsu
General Partner · Actual VC
Aaron Hsu is a General Partner at Actual VC, where he focuses on supporting founders who are building innovative companies aimed at changing the world. With a background in technology and venture capital, he identifies and invests in early-stage startups with high potential impact. His role involves mentoring entrepreneurs and driving investments in transformative technologies.
Adrian Killan
nullMango Medical
Adrian Killan is a professional at Mango Medical, where he is involved in medical technologies, as indicated by his participation in biotech-related events. He has spoken at the Ligandal Biotech Summit, demonstrating his expertise in the biotech sector. His work likely contributes to innovations in healthcare based on available context.
Ainur Nygmet
nullFaberge Labs
Ainur Nygmet is a professional associated with Faberge Labs, where she holds a role in the deep tech sector. She has spoken at the Ligandal Biotech Summit, indicating her involvement in biotech-related discussions. Her expertise is inferred from these engagements, focusing on advanced technologies in biotechnology.
Andre Watson
CEO & Founder · Ligandal
Andre Watson is the CEO and Founder of Ligandal, a company involved in biotechnology as indicated by his participation in events like the Ligandal Biotech Summit. His role focuses on leading innovations in the biotech sector, drawing from his position alongside other industry experts. Watson's expertise is evident through his speaking engagements and associations in the field.
Andrew Hessel
Biotechnologist, Futurist, and Founder of the Human Genome Project-Write · Genome Project-write
Andrew Hessel is a biotechnologist and futurist known for his work in synthetic biology and genomics. He is the founder of the Genome Project-write, an initiative aimed at synthesizing the human genome, and has contributed to advancements in biotechnology through various research and speaking engagements. In his current role, he continues to explore the future applications of genetic engineering and biotechnology.
Curtis Wu
General Partner · Terran Applied
Curtis Wu is a General Partner at Terran Applied, bringing expertise in venture capital and business strategy with his MBA background. He has spoken at events like the Ligandal: Future of Biotech Summit, indicating his involvement in emerging technologies within the biotech sector. His role focuses on investing in innovative deep tech areas, leveraging his professional experience to support advancements in these fields.
David Sinclair
Professor of Genetics · Harvard Medical School
David Sinclair is a professor in the Department of Genetics at Harvard Medical School and a leading researcher in the biology of aging. He is known for his work on sirtuins and NAD+ metabolism, aiming to develop interventions that could extend human healthspan.
Emily Capra
PhD · McKinsey & Company
Emily Capra holds a PhD and serves as a consultant at McKinsey & Company, where she applies her expertise in strategic advising for various industries. She has spoken at events such as the Ligandal Biotech Summit, highlighting her involvement in biotechnology-related discussions. Her background bridges academic research and professional consulting in deep tech fields.
Ester Caffarel-Salvador
Director, Strategic Innovation · Chiesi USA
Ester Caffarel-Salvador is a biomedical engineer known for her work in innovative drug delivery systems and ingestible sensors. She has a background in academic research, including contributions at institutions like MIT, and has transitioned to industry roles focused on strategic innovation. In her current position, she leads initiatives at Chiesi USA to advance pharmaceutical technologies.
Gina El Nesr
ABD · Stanford Biophysics
Gina El Nesr is a PhD candidate (ABD) in Biophysics at Stanford University, where she conducts advanced research in biophysical sciences. She has presented at events such as the Ligandal Biotech Summit, highlighting her expertise in biotech-related applications. Her work focuses on the intersection of biology and physics, contributing to innovative scientific advancements.
Greg Timblin
PhD · Inapill
Greg Timblin, PhD, is a professional at Inapill, where he holds expertise in biotechnology based on his participation in events like the Ligandal Biotech Summit. His background includes advanced research, as indicated by his PhD qualification, contributing to innovations in the biotech sector. He is recognized for his involvement in deep tech discussions at industry conferences.
Ileana Pirozzi
Head of Healthcare Ventures · Lingotto Innovation
Ileana Pirozzi is the Head of Healthcare Ventures at Lingotto Innovation, where she leads investments in healthcare technologies and innovations. With a background in venture capital, she has been involved in identifying and supporting startups that advance medical solutions. Her role focuses on strategic investments in the health sector to drive impactful developments.
James Lim
Investment Professional · In-Q-Tel
James Lim is an investment professional at In-Q-Tel, a company that focuses on investing in advanced technologies for the U.S. intelligence community. With a JD and MBA, he brings expertise in legal and business aspects to his role in identifying and supporting innovative tech ventures. He has participated in events such as the Ligandal: Future of Biotech Summit, indicating his involvement in biotech-related discussions.
James Zou
Professor of Biomedical Data Science · Stanford University
James Zou is a Professor of Biomedical Data Science at Stanford University, where he leads research in artificial intelligence and machine learning, focusing on ethical AI and its applications in biomedicine. He earned his PhD in Electrical Engineering and Computer Science from Harvard University and has published extensively in top-tier journals on topics like AI fairness and healthcare data analysis. Zou's notable achievements include receiving the Sloan Research Fellowship and serving as a principal investigator on projects funded by the National Institutes of Health. His expertise encompasses machine learning, statistical methods, and their integration with biological sciences, contributing to advancements in AI-driven medical diagnostics and ethical algorithm design.
Katie Kuo
CEO & Founder · Atomistic Insights
Katie Kuo is the CEO and Founder of Atomistic Insights, a company specializing in AI-driven solutions for materials discovery and atomic-scale simulations. She has established the company to advance innovations in materials science, drawing on expertise in technology and entrepreneurship. Under her leadership, Atomistic Insights is making strides in applying AI to real-world scientific challenges.
Louis Metzger
CEO & Founder · dGenThera
Louis Metzger, PhD, is the Co-founder and CEO of dGenThera, a radiopharmaceutical startup that develops theranostics using novel halogen chemistry to treat solid tumors. With prior experience at Novartis Pharma and leadership roles in synthetic biology and gene therapy startups, he brings extensive expertise in biotechnology and pharmaceuticals. He is passionate about extending healthspan for cancer survivors by creating targeted radiotherapeutics that aim for long-term remission while minimizing damage to healthy tissues.
Matt O’Brien
CEO · Snowcrash Labs
Matt O'Brien is the CEO of Snowcrash Labs, a company focused on cutting-edge AI and machine learning technologies aimed at solving complex problems in defense and national security. He holds a degree in Computer Science from Stanford University and has over 15 years of experience in the tech industry, including roles at leading firms like Google and defense contractors. Prior to founding Snowcrash Labs, Matt led innovative projects in autonomous systems and AI applications for government and private sectors, earning recognition for his contributions to advanced data analytics. Under his leadership, Snowcrash Labs has developed proprietary AI tools that enhance decision-making in high-stakes environments, such as cybersecurity and intelligent automation. Matt is dedicated to advancing ethical AI practices and continues to drive the company's growth in emerging technologies.
Michael Dubrovsky
CEO · SiPhox
Michael Dubrovsky is the founder and CEO of SiPhox, a company focused on developing advanced at-home health diagnostics using nanotechnology. With a background in engineering and entrepreneurship, he has led SiPhox to innovate in portable health testing solutions. Currently, he works on making health monitoring more accessible through cutting-edge technology.
Nicole Fay
PhD · Nutcracker Therapeutics
Nicole Fay holds a PhD and is affiliated with Nutcracker Therapeutics, a company specializing in RNA therapeutics. She has spoken at events like the Ligandal Biotech Summit, indicating her involvement in biotechnology discussions. Her expertise likely centers on advanced therapeutic technologies within the biotech field.
Vivek Sharma
MS, ME, MBA · Asha Medical
Vivek Sharma holds a Master of Science, Master of Engineering, and Master of Business Administration, providing him with a strong interdisciplinary background in science, engineering, and business. He is associated with Asha Medical, where he applies his expertise in the medical field. Sharma has spoken at events such as the Ligandal Biotech Summit, indicating his involvement in biotechnology discussions.